JGICX | VITSX | JGICX / VITSX | |
Total Expense Ratio | 1.68 | 0.03 | 5,600% |
Annual Report Gross Expense Ratio | 1.69 | 0.03 | 5,633% |
Fund Existence | 16 years | 28 years | - |
Gain YTD | 12.694 | 10.352 | 123% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.86B | 1.95T | 0% |
Annual Yield % from dividends | 0.01 | 1.17 | 1% |
Returns for 1 year | 2.94 | 18.04 | 16% |
Returns for 3 years | 19.38 | 63.66 | 30% |
Returns for 5 years | 29.50 | 84.98 | 35% |
Returns for 10 years | 80.65 | 224.85 | 36% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JNGLX | 70.49 | 0.55 | +0.79% |
Janus Henderson Global Life Sciences D | |||
QSERX | 19.38 | 0.02 | +0.10% |
AQR Small Cap Multi-Style R6 | |||
VIMSX | 79.00 | -0.11 | -0.14% |
Vanguard Mid Cap Index Investor | |||
VALLX | 44.72 | -0.07 | -0.16% |
Value Line Larger Companies Focused Inv | |||
APDTX | 24.96 | -0.24 | -0.95% |
Artisan Focus Fund Advisor |